| Primary |
| Ulcerative Colitis |
100.0% |
|
| Procedural Complication |
100.0% |
|
| Secondary |
| Colitis Ulcerative |
36.0% |
| Crohn's Disease |
24.0% |
| Product Used For Unknown Indication |
20.0% |
| Drug Use For Unknown Indication |
8.0% |
| Contraception |
2.0% |
| Diverticulum |
2.0% |
| Osteoporosis |
2.0% |
| Proctitis Ulcerative |
2.0% |
| Respiratory Tract Infection |
2.0% |
| Spondyloarthropathy |
2.0% |
|
| Myocarditis |
26.7% |
| Pyrexia |
13.3% |
| Anal Fistula |
6.7% |
| No Therapeutic Response |
6.7% |
| Proteinuria |
6.7% |
| Rash Generalised |
6.7% |
| Respiratory Tract Infection |
6.7% |
| Thrombocytopenia |
6.7% |
| Thrombosis |
6.7% |
| Tubulointerstitial Nephritis |
6.7% |
| Vaginal Haemorrhage |
6.7% |
|
| Concomitant |
| Crohn's Disease |
33.0% |
| Colitis Ulcerative |
24.9% |
| Product Used For Unknown Indication |
14.6% |
| Drug Use For Unknown Indication |
10.7% |
| Rheumatoid Arthritis |
3.0% |
| Premedication |
2.3% |
| Hypertension |
1.3% |
| Prophylaxis |
1.3% |
| Inflammatory Bowel Disease |
1.2% |
| Colitis |
1.0% |
| Osteoporosis |
0.9% |
| Osteoporosis Prophylaxis |
0.9% |
| Pain |
0.8% |
| Parkinson's Disease |
0.8% |
| Arteriosclerosis |
0.7% |
| Analgesic Therapy |
0.6% |
| Depression |
0.6% |
| Ankylosing Spondylitis |
0.5% |
| Hypersensitivity |
0.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.5% |
|
| Weight Decreased |
11.6% |
| Colitis Ulcerative |
9.9% |
| Crohn's Disease |
6.6% |
| Vomiting |
6.6% |
| Hepatosplenic T-cell Lymphoma |
5.8% |
| Pyrexia |
5.8% |
| Rectal Haemorrhage |
5.8% |
| Sepsis |
5.8% |
| Fistula |
5.0% |
| Death |
4.1% |
| Pemphigoid |
4.1% |
| Haematochezia |
3.3% |
| Nasopharyngitis |
3.3% |
| Pleurothotonus |
3.3% |
| Pneumonia |
3.3% |
| Pulmonary Embolism |
3.3% |
| Sudden Death |
3.3% |
| Tachycardia |
3.3% |
| Weight Increased |
3.3% |
| Abdominal Neoplasm |
2.5% |
|
